Delivery Order SPE2DB25D3012-SPE2DB25FWXVH
- Not listed
- The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,395.32 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Humalog 100 Unit/mL vial 10mL insulin medication. The contract is valued at $4,766.40 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded without set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order valued at approximately $546 to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml vials of Humalog insulin. As the prime contractor, Amerisourcebergen will provide 10 ml vials of the drug to fulfill requirements under the delivery order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. The pricing structure is firm fixed...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWXVHDelivery Order
The Defense Logistics Agency awarded a $1,113.80 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a critical pharmaceutical distributor and healthcare solutions provider to the Defense Health Agency and military healthcare systems, AmerisourceBergen leverages this comprehensive prime vendor vehicle to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The current delivery order for Humalog insulin represents one of many pharmaceutical product fulfillments under this strategic global pharmaceutical support contract that serves military and veteran healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/5/25 |